AHA Scientific Sessions 2025 Abstract
RN0361, an siRNA Directed Against ApoC3 Demonstrates Potent and Durable Reduction of ApoC3 and Triglyceride Over 6 Months in the Clinic
Trial in peopleInterventions
The paper
Rona Therapeutics
AHA Scientific Sessions 2025 Abstract, 3 Nov 2025
Presented at AHA Scientific Sessions 2025, abstract 4361462
